This blog challenges portrait of Sweden, as a country with well implemented value-based health care framework, based on our experience.
Blog
20 Dec 2016
20 Dec 2016
The value of real world data is frequently debated. This is very much dependent on the perspective of the person who is reviewing the data.
31 May 2016
We have recently reviewed the number of HTA reports regarding imaging modalities. We can see somewhat of a reduction during 2015 compared to 2014. The trend for the first 4 months of 2016 would indicate an increase compared to the year before. Subscribe to our HTA services to stay on top of what is happening: http://htasearch.synergus.com/
30 May 2016
There are many aspects that are changing with the introduction of the new 137h process to assess the benefit of the new innovations coming to market. We will provide more information about all of these changes in a webinar in a few weeks.
18 May 2016
The German landscape for introduction of new technologies and drugs is changing dramatic. For drugs, the introduction of the Amnog process has been a drastic change. Now the medical devices are undergoing a similar drastic change, where new medical technologies coming to market through the innovation funding pathway have to go through a benefit assessment.
16 May 2016
An overview of the HTA activity by different organisations in the United Kingdom
11 May 2016
An overview of the HTA activity by the Dutch Zorginstituut, who will now have the important role of beeing EUnetHTA Secretariat.
04 May 2016
The French Haute Autorité de Santé is one of the HTA organisations in Europe with most publications.
12 Apr 2016
Review of case studies from England, France and Germany